Notice: WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /nas/content/live/utcampaigns/wp-includes/functions.php on line 5313

The University of Texas Health at San Antonio has enabled the launch of more than 50 companies from technologies developed by UTHSA faculty and staff.

Updated January 13, 2021

 

1976

Avox (Acquired, Acriva) – Lightweight, battery-powered, portable blood analyzer, known as an oximeter, to measure oxygen, hemoglobin and other substances in blood and also useful for diagnosing problems, such as, heart defects.

 

1993

Osteobiologics (Acquired, 2006, Smith-Nephew) – Innovative bioabsorbable bone graft substitutes (BGS) to repair cartilage defects in the knee

 

1998

Vidacare (Acquired, 2013, Teleflex) – Patented power driver and needle system to access the intraosseous space for a variety of medical, diagnostic and therapeutic purposes. Vidacare’s proprietary devices are the recognized technology standard used in a broad range of applications including vascular access, emergency medicine, oncology, and spinal surgery.

 

1999

Advanced Bio ProSthetic, Ltd. – Palmaz cardiovascular stent

 

2001

Xenotope Diagnostics, Inc. – Develops novel solutions for global diseases through the implementation of its expertise in infectious disease research and unique discovery platform.

 

2004

Admittance Technologies – Innovative electrical engineering solutions

Cerebral Eidetics – Revoluntionary core-technology, image-guided, robotic transcranial magnetic stimulation (irTMS). irTMS is a “personalized medicine” individually mapping each patient’s brain connectome with functional MRI to create an optimized treatment plan.

 

2005

Cardio Spectra (Acquired, 2007, Volcano) – Innovative Optical Coherence Tomography (OCT) imaging technology for the diagnosis and treatment of diseases

Numira Biosciences, Inc. – High resolution MicroCT small animal imaging services

 

2010

Paragonix Technologies, Inc. – SherpaPakTM  transport systems for donor organ preservation and transportation

 

2011

StemBioSys, Inc. – Enabling innovative regenerative medicine solutions with the novel High Performance Microenvironment (HPMETM)  platform. Stem cell technologies for research and therapeutic pipelines

 

2012

Cardiovate, Inc. – Innovative devices for repair of cardiovascular conditions

Rapamycin Holdings (DBA, Emtora, Inc.) – Leveraging a platform of Rapamycin-related discoveries applicable to the veterinary and human markets. These discoveries could have dramatic implications in improving an individual’s health-span and in fighting age-related medical conditions.

 

2015

Astrocyte Pharmaceuticals, Inc. – Developing innovative neuroprotection  therapies for traumatic brain injury (TBI), concussions, stroke, and neurodegenerative disorders 

Digital Biopsy

Echolase, Inc. – Revolutionary acoustic sensor based on the patent pending probe beam deflection technology (PBDT)

Lung Therapeutics, Inc.

NanoTX Therapeutics, Inc.

 

2017

AlaMab Therapeutics, Inc.

GuadiumRX, LLC

Terrona

Vascular Perfusion Solutions, Inc.

Vindolar, LLC

 

2018

Druksys, LLC

First Ascent Biomedical Corp

MedCognition

NuAxon Research, Inc.

 

2019

Advanced Surgical Retractor Systems, Inc.

Anaxcel, LLC

Strong North Wind

Vida Medical Devices

 

2020

ASR Systems Inc.

Atomic Therapeutics, Inc.

CardioVol

CereNovum, Inc.

EmergenceMed, LLC

Exprimon

HemaCure

Hera Biotech

InflammatoRX

Lonestar Sciences Inc.

Muen LLC

Novuprin

Olifant Medical, Inc.

OraLiva, Inc.

Protectum Oncology

Riverwalk Therapeutics, Inc.

SygnaMap, Inc.

Xtraction

Secured By miniOrange